Clear all
2015 • Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.

Works in BIP! associated with the specified OpenAIRE research product

Gregory J. Dore, Brian Conway, Yan Luo, Ewa Janczewska, Brygida Knysz, Yan Liu, Adrian Streinu-Cerce (...)
Journal of Hepatology · 2016
Virology |         Internal medicine |         Gastroenterology |